Tech Transfer eNews Blog
University-Industry Engagement Advisor

New I-Corps entrepreneurship training program to launch at U of Alabama-Birmingham

By Jesse Schwartz
Published: July 11th, 2018

The University of Alabama-Birmingham (UAB) Center for Clinical and Translational Science (CCTS) has received a $1 million award from the National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to train researchers on taking their innovations to market.

Over a two-year period, the CTSA Collaborative Innovation Award will support the creation of an I-Corps@NCATS program curriculum, which addresses the particular challenges of tech transfer in academic medical centers through a five-week course offered several times a year.

The program helps researchers determine the commercial viability of their research, develop an investment-ready business strategy, establish a network of innovation partners, connect with mentors, and develop greater self-confidence about how to value the impact of their work.

“Taking a new technology, protocol or invention from concept to commercialization is often difficult for biomedical scientists and engineers in academic medical centers,” says Molly Wasko, associate dean for research, innovation and faculty success at the UAB Collat School of Business.

“The reality in academic medical centers is that innovative ideas originating on campus are often met with seemingly insurmountable obstacles impeding their translation into improved patient care and outcomes,” Wasko says. “Our program is tailored to meet the needs of biomedical scientists and guide them as they seek commercialization.”

CCTS will partner with several other CTSA programs across the country as part of the new program, including the Georgia Institute of Technology, the University of California-Davis, the University of Michigan, the University of Massachusetts Medical School, and more.

Source: UAB News

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment